Does the LPL rs328 G (447X) allele lower triglycerides and raise HDL cholesterol?

Lipoprotein Lipase (LPL) is a critical enzyme in lipid metabolism, responsible for breaking down triglycerides in the bloodstream. The rs328 G allele (also known as the 447X or Ser447Ter variant) is a well-documented "gain-of-function" mutation. In this variant, a premature stop codon results in a truncated protein that is more stable and more efficiently secreted than the common version, leading to enhanced enzymatic activity.

Clinical effectiveness and lipid profiles

The association between the LPL rs328 G allele and improved lipid profiles is robust across diverse populations.

• Triglyceride Reduction: Carriers of the G allele typically exhibit a 5% to 16% reduction in plasma triglyceride levels compared to those with the CC genotype. Large-scale longitudinal studies, such as the CARDIA and NPHSII cohorts, consistently demonstrate this effect.
• HDL Elevation: The G allele is associated with significantly higher high-density lipoprotein (HDL) cholesterol levels. Clinical data suggest an average increase of approximately 0.11 mmol/L (4.25 mg/dL) in HDL-C per G allele.
• Cardiovascular Impact: Due to its role in lowering triglycerides and raising HDL, this variant is often associated with a reduced risk of coronary artery disease and improved cardiovascular health outcomes in long-term observational studies.

Mechanistic explanations

The lipid-lowering effects of the rs328 G allele are driven by the increased catalytic efficiency of the truncated LPL protein:

• Accelerated Hydrolysis: The enhanced activity of the 447X enzyme allows for more rapid hydrolysis of triglycerides within chylomicrons and very-low-density lipoproteins (VLDL).
• HDL Maturation: As LPL breaks down triglyceride-rich lipoproteins, it releases surface lipids (phospholipids and free cholesterol). these components are essential for the formation and maturation of HDL particles.
• Reduced Lipid Exchange: By lowering the concentration of circulating VLDL, the variant indirectly limits the activity of Cholesteryl Ester Transfer Protein (CETP). This reduces the exchange of cholesterol out of HDL particles, thereby maintaining higher HDL-C levels.

Bottom line

The LPL rs328 G (447X) allele is strongly associated with lower triglycerides and higher HDL cholesterol. This is achieved through a gain-of-function mechanism that increases the stability and secretion of the LPL enzyme, leading to more efficient clearance of fats from the blood.